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Obese individuals exhibit skeletal muscle metabolic inflexibility by failing to increase fat 
oxidation and genes linked with mitochondrial biogenesis in response to a high-fat diet (HFD) 
and lipid incubation in cell culture.  Exercise training can increase skeletal muscle fatty acid 
oxidation (FAO) and mitochondrial content in the skeletal muscle of the obese, although whether 
it can normalize the response to excess lipid is unclear.  The purpose of this dissertation was to 
determine whether metabolic flexibility in response to lipid could be rescued by short-term 
aerobic exercise training (study 1) and chemically uncoupling primary human skeletal muscle 
cells (HSkMC) to increase cell energy expenditure (study 2) in obese skeletal muscle.  The 
hypotheses were that 1) obese individuals would exhibit skeletal muscle metabolic inflexibility 
in response to a 3d eucaloric high-fat diet (HFD; 70% total calories) in study 1, a defect that 
would persist in response to 24h lipid incubation in HSkMC (study 2); and 2) 10 consecutive 
days of aerobic exercise training (study 1), and mild uncoupling in vitro (study 2) would 
normalize the response to excess lipid in the skeletal muscle of obese individuals.  Unlike the 
lean, obese individuals did not increase skeletal muscle FAO in response to a 3d HFD while 
 
 
 
 
sedentary (study 1) and did not increase protein content of Complex I, Complex III, and COX IV 
in response to 24h lipid incubation in HSkMC (study 2), supporting our hypothesis of lipid-
induced metabolic inflexibility in obese skeletal muscle.  Exercise training combined with a HFD 
produced a similar increase in FAO and citrate synthase (CS) activity in lean and obese 
individuals (study 1), indicating that HFD-induce metabolic flexibility was restored with exercise 
training regardless of obesity status.  Incubation with the chemical uncoupler FCCP and lipid 
exhibited a treatment effect for Complex I and Complex III, although the latter appeared to be 
driven by the robust lean response, and increased COX IV content in the lean only.  Therefore, 
lipid-induced metabolic inflexibility is persistent in cell culture, and increasing energy 
expenditure in vitro does not fully restore the response to lipid in a manner similar to in vivo 
exercise training. 
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CHAPTER 1: LITERATURE REVIEW 
Obesity and Metabolic Flexibility 
 Obesity has become the most prevalent disorder of the 21
st
 century, affecting over one-
third of the United States population (~72 million individuals) and contributing to at least 
112,000 preventable deaths per year as well as diabetes, heart disease, and disability (6).  The 
skeletal muscle of lean, healthy individuals has the capacity to shift between carbohydrate and 
fat utilization depending on fuel availability, a phenomenon known as metabolic flexibility (11).  
One of the critical aspects of obesity which may contribute to an increased incidence for disease 
is a pronounced impairment in metabolic flexibility, particularly in skeletal muscle.  
This dissertation focused on the effects of increased lipid presence on lipid oxidation in 
respect to metabolic flexibility and obesity.  In lean individuals, a high-fat diet has been shown to 
increase whole-body lipid oxidation (20), as well as transcription of genes involved in fatty acid 
transport (FAT/CD36), oxidation (HAD) (3), and substrate switching (PDK4) (15) in skeletal 
muscle.  This indicates that lean individuals are able to adjust to lipid overload and increase 
oxidation, indicative of metabolic flexibility.  However, there is evidence that this increase in 
lipid oxidation in response to a high-fat diet does not occur in obese individuals (i.e. they are 
metabolically inflexible) (9).  This mismatch between lipid availability and oxidation ultimately 
leads to increased presence of triglycerides and fatty acid intermediates in skeletal muscle, which 
has been implicated in the development of insulin resistance and type 2 diabetes (14).  A reduced 
capacity to oxidize fat has also been linked to weight gain in humans (16), and skeletal muscle 
cells cultured from diabetic individuals have reduced lipid oxidation when compared to 
nondiabetic controls (7), suggesting that reduced lipid oxidation is a persistent trait.  Our recent 
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data has shown that 5 d of a 60% fat diet increases skeletal muscle palmitate oxidation and 
expression of genes involved in lipid oxidation in lean, but not obese men and women (2).  The 
molecular mechanism behind this repressed response to lipid in skeletal muscle with obesity is 
unclear as well as the impact of an intervention such as exercise training. 
Mitochondrial Content, Obesity, and Lipid Oxidation 
Since complete lipid oxidation exclusively involves mitochondria, studying 
mitochondrial content and/or function is critical in determining the capacity to increase lipid 
oxidation.  Studies have shown that obese individuals have reduced activities of β-hydroxyacyl 
CoA dehydrogenase (HAD) and citrate synthase (CS), as well as reduced cytochrome c oxidase 
IV (COX IV) content (8,10,12,19) compared to their lean counterparts which suggests that 
deficiencies with obesity may simply be a function of reduced mitochondrial content.  In support, 
a study showed that obese individuals had reduced fatty acid oxidation (FAO) in skeletal muscle 
homogenates, but FAO did not differ after adjusting for mitochondrial mass, again implicating 
reduced mitochondrial content (8).  Recent research from our laboratory showed the decreased 
FAO in obese human myotubes was abolished after normalization to mitochondrial DNA 
(mtDNA) and COX IV content, respectively (4).  This finding in cell culture suggests that the 
reduction in mitochondrial content is imprinted in the genetic program of primary myotubes and 
may play a key role in determining the response to exogenous lipid.   
Can Exercise Improve Metabolic Flexibility in Skeletal Muscle? 
Aerobic exercise training increases oxidative enzyme activities, and even short-term 
exercise training (9 days) has been shown to increase the transcription of genes involved in lipid 
transport in lean individuals (23).  Additionally, exercise is an intervention that has had 
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promising results in increasing the capacity for lipid oxidation in obese individuals.  For 
example, gastric bypass-induced weight loss did not increase lipid oxidation in obese individuals, 
but ten consecutive days of training normalized lipid oxidation to the level of lean individuals 
who underwent the same exercise training (1).  Additionally, mitochondrial content and electron 
transport chain activity increased after a 16-week diet and exercise program, whereas weight loss 
alone actually decreased mitochondrial size, strongly suggesting that exercise is a potent 
stimulus for increasing mitochondrial content and/or function in overweight/obese individuals 
(22).  Whether metabolic flexibility can be restored with exercise training in obese individuals 
has not been investigated; however, our finding that 10 days of exercise restored oxidative 
capacity, as well as research demonstrating increased mitochondrial content with exercise 
training, strongly suggests that it can. 
Multiple signaling pathways associated with exercise, namely Ca
2+
/calmodulin-
dependent protein kinases (CaMKs), AMP-activated protein kinase (AMPK), and p38 mitogen-
activated protein kinase (MAPK), likely stimulate mitochondrial biogenesis (13).  However, the 
convergence of these pathways and how they directly or indirectly control mitochondrial 
biogenesis is complex.  Furthermore, manipulation of kinase activity or gene expression in vitro 
(i.e. genetic disruption of AMPK) may lead to non-physiological compensatory mechanisms 
created by the cell in an attempt to maintain homeostasis.  Therefore, an in vitro exercise 
mimetic that increases overall metabolic activity within the cell may be optimal for studying the 
effects of metabolic pathways activated by contractile activity.  In this respect, low 
concentrations of chemical uncouplers (FCCP, 2,4-dinitrophenol) have been used to study 
energy homeostasis in 10T ½ fibroblasts (17), intramyocellular lipid oxidation in human 
myotubes (5), and triglyceride (TG) synthesis in 3T3-L1 adipocytes (18, 21).  Chemical 
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uncouplers disrupt the proton gradient (the driving force behind ATP production by the electron 
transport chain) across the inner mitochondrial membrane, which causes protons to leak back 
into the mitochondrial matrix.  The dissipation of this proton gradient leads to increased cell 
respiration and substrate utilization in an attempt to maintain intracellular ATP, which triggers 
the cell to compensate for this temporary energy depletion via intracellular signaling.  Rohas et al 
demonstrated that peroxisome proliferator-activated receptor γ co-activator (PGC-1), oxidative 
phosphorylation (OXPHOS) gene expression, and mitochondrial density increased after 16 h of 
mild uncoupling in fibroblasts.  We utilized this property to determine if pharmacological 
uncoupling alone would increase mitochondrial content and cell respiration and restore the 
metabolic flexibility to lipid exposure in the skeletal muscle of obese individuals 
Previous research strongly suggests that the skeletal muscle of obese individuals is 
metabolically inflexible in response to high lipid loads in terms of increasing lipid oxidation, a 
defect that persists in cell culture.  Short-term exercise training has been shown to increase 
skeletal muscle lipid oxidation, but whether it can improve metabolic flexibility in response to 
lipid and if the increase in energy demand is the primary mechanism involved in these positive 
adaptations is unknown.  The purpose of this dissertation is 1) determine whether the metabolic 
inflexibility in response to lipid in obese individuals can be rescued by short-term exercise 
training and 2) if increasing energy demand by chemical uncoupling is the primary mechanism 
involved with the positive changes seen with exercise. 
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CHAPTER 2: SHORT-TERM EXERCISE TRAINING INCREASES HIGH-FAT DIET-
INDUCED LIPID OXIDATION IN LEAN AND OBESE INDIVIDUALS 
Abstract 
Obese individuals fail to increase expression of lipid oxidation genes in response to a high-fat 
diet.  Short-term exercise increases skeletal muscle lipid oxidation in obese individuals, although 
whether it can improve high-fat diet-induced lipid oxidation is unclear. The purpose of this study 
was to compare skeletal muscle lipid oxidation response to a 3-day high-fat diet (HFD) and 10 
consecutive days of aerobic exercise training in sedentary lean and obese individuals.  Twelve 
lean (age 21.8±1.1y; BMI 22.6±0.7 kg/m
2
) and 10 obese (age 22.4±0.8y; BMI 33.7±0.7 kg/m
2
) 
males consumed a HFD (70% of calories) for 3d.  Ten consecutive days of aerobic exercise 
(1h/d, 70% VO2peak) on a cycle ergometer was performed, and the diet was repeated during 
days 8-10 of exercise training.  Fasting muscle biopsies were taken before and after each HFD 
and fatty acid oxidation (FAO) measured with end-labeled [1-
14
C] palmitate.  Indices of 
mitochondrial content were determined using Western blots and enzyme activity assays.  Lean 
subjects increased FAO (mean ±SEM 27.3±7.4%, p=0.03) in response to a 3-day HFD, 
significantly more than their obese counterparts (1.0±7.9%).  A HFD and exercise increased 
FAO by 64.0±32.8% in leans and by 70.4±34.8% in obese, compared to pre-diet, pre-exercise 
values.  Citrate synthase (CS) and beta-hydroxyacyl coenzyme A dehydrogenase (HAD) 
activities followed a similar pattern, with overall treatment effects of 7d exercise and 10d 
exercise plus 3d HFD.  Short-term exercise training rescued the FAO response to a HFD in obese 
individuals.  Further research should investigate mechanisms responsible for improvement in 
HFD-induced skeletal muscle FAO. Keywords: skeletal muscle, fat oxidation, mitochondria, 
physical activity  
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Introduction 
The prevalence of obesity has been increasing rapidly and is strongly associated with the 
development of insulin resistance and type 2 diabetes (11).  An important indicator of metabolic 
health is metabolic flexibility, which is the ability to adjust substrate utilization based on 
substrate availability (18).  For example in lean individuals, fatty acid oxidation at the whole-
body level increases rapidly in response to a high fat diet; to the contrary, obese individuals 
display an impaired capacity to increase lipid oxidation with increased dietary lipid (1, 13, 17, 
26).  This inability to increase lipid oxidation when lipid presence is elevated creates a condition 
of positive fat balance resulting in lipid storage (34), which in skeletal muscle may lead to 
ectopic lipid accumulation (26), lipid peroxidation (28), and excessive increases in lipid 
intermediates such as diacylglycerol and ceramide resulting in intracellular lipotoxicity (21).   
Skeletal muscle is a major contributor to whole-body lipid utilization and thus plays a 
role in relation to metabolic flexibility.  In lean individuals a high-fat diet increased the 
transcription of genes involved in fatty acid transport and oxidation (3, 6, 23) in skeletal muscle.  
However, obese individuals did not increase the transcription of genes that control skeletal 
muscle lipid metabolism as compared to their lean counterparts in response to a 5d high fat diet 
(3), again demonstrating that inflexibility persists in skeletal muscle with obesity. 
Endurance-oriented exercise training increases lipid oxidation in skeletal muscle in both 
lean and obese individuals.  An increase in mitochondrial content has been reported with as little 
as 7 days of aerobic training (31). Furthermore, our studies have shown that formerly severely 
obese (BMI>40 kg/m
2
) individuals who lost weight via gastric bypass surgery increased skeletal 
muscle lipid oxidation to the level of an exercise-trained lean individual with 10 days of aerobic 
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exercise (2).  This suggests that obese individuals are capable of responding to exercise in terms 
of increasing the capacity for lipid oxidation in skeletal muscle.  However, it is not evident if the 
capacity for metabolic flexibility in response to ingested lipid is also restored.  The purposes of 
the present study were to 1) specifically determine if the skeletal muscle of obese individuals is 
metabolically inflexible in response to a short-term high-fat diet in terms of appropriately 
increasing lipid oxidation; and 2) to determine if exercise training can correct any impairment in 
metabolic flexibility evident with obesity. 
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Methods 
Subjects. Twelve lean (BMI≤25 kg/m2) and 10 obese (BMI≥30 kg/m2) male subjects ages 18-
30y volunteered to participate.  Subjects were not involved in an aerobic training program, as 
determined by a physical activity questionnaire and verbal questioning, and were asked to not 
change their physical activity patterns throughout the duration of the study. Participants filled out 
a medical history to confirm they were free from disease, did not smoke, and were not taking any 
medications known to influence carbohydrate or lipid metabolism.  Subjects were weight-stable 
(±2 kg over the past 3 months) and nonsmokers.  The experimental procedure and associated 
risks were explained in written and oral format, and informed consent obtained. The study was 
approved by the East Carolina Policy and Review Committee on Human Research and was in 
accordance with the Declaration of Helsinki. 
Study design. Each participant consumed a high-fat diet for 3 days while sedentary.  After a 2-3 
week washout period, subjects exercised for 10 consecutive days and consumed the high-fat diet 
at days 8-10 of exercise training (Fig. 2.1).  Skeletal muscle biopsies were obtained from the 
vastus lateralis after a 12h overnight fast on the morning that the high fat diet was initiated and 
the morning after the 3 days of the diet. 
Diet. The high-fat diet consisted of approximately 70 percent fat, 15 percent carbohydrate, and 
15 percent protein.  Energy content for each individual was determined from the Harris-Benedict 
equation (15).  Food was provided and subjects logged their intake. The day prior to 
commencement of each of the high-fat diets, subjects were provided an isocaloric diet consisting 
of approximately 25 percent fat, 15 percent protein, and 60 percent carbohydrates.  All diets and 
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food logs were analyzed by Nutritionist Pro Nutrition Analyst Software (Axxya Systems LLC; 
Stafford, TX) to ensure correct macronutrient composition. 
Exercise training. An incremental maximal exercise test on an electronically braked cycle 
ergometer was performed to determine VO2peak during the screening process.  Participants then 
exercised 60 min/d at 70% VO2peak for 10 consecutive days.  All training was supervised and 
performed in the laboratory setting; heart rate was monitored throughout each training session 
and VO2 measurements were taken periodically to ensure proper workload.  Net calories burned 
during exercise training were estimated using the VO2 measurements and the resulting energy 
added to the diets provided during days 8-10 of exercise.  Exercise was performed 14-18h before 
the muscle biopsies on day 7 and day 10. 
Muscle analyses. Fatty acid oxidation (FAO) was measured as described previously (2, 16, 19). 
Briefly, 50-60 mg of muscle tissue was collected in 200 µl of a buffer containing 250 mM 
sucrose, 1mM EDTA, 10mM Tris-HCl, and 2 mM ATP, pH 7.4.  Samples were minced with 
scissors to remove excess fat and connective tissue and diluted 20-fold with additional buffer.  
Tissue was placed on ice and homogenized with a Teflon pestle for 30s.  Forty microliters of 
homogenate was added to the top well of a sealed, modified 48-well plate that contained a 
channel connecting to the adjacent trap well, which allowed for the passage of CO2 liberated by 
the complete oxidation of [1-
14
C] palmitate.  The bottom trap well contained 1 N sodium 
hydroxide to collect the 
14
CO2 given off by the oxidation procedure.  To initiate the reaction, 160 
µl of a reaction buffer composed of the following was added to the top wells: 0.2mM palmitate 
([1-
14
C]palmitate at 0.5 µCi/ml), 100 mM sucrose, 10 mM Tris-HCl, 5mM potassium phosphate, 
80 mM potassium chloride, 1mM magnesium chloride, 0.1 mM malate, 2 mM ATP, 1mM 
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dithiothreitol, 0.2 mM EDTA, 1 mM L-carnitine, 0.5 mM coenzyme A, and 0.5% fatty acid-free 
bovine serum albumin, pH 7.4. The samples were incubated in a 37°C water bath for 30 min, at 
which point 100 µl of 70% perchloric acid was added to terminate the reaction.  The plate was 
placed on a shaker for 1h to ensure complete transfer of CO2 into the bottom well.  Label 
incorporation into 
14
CO2 was determined by scintillation counting using 4 ml of Uniscient BD 
(National Diagnostics, Atlanta, GA). Incomplete oxidative products (acid-soluble metabolites, 
ASM) remaining in the top well were measured as described previously (19).  
A 10-15 mg piece of muscle was homogenized at 4°C using a Bullet Blender (Next 
Advance, Averill Park, NY) in a lysis buffer containing 50 mM HEPES, 12 mM sodium 
pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA, 1% Triton X-100, and 0.1% SDS and 
supplemented with protease and phosphatase inhibitors (Sigma-Aldrich).  Samples were rotated 
end-over-end on a rotating wheel for 1h at 4°C and centrifuged at 21,000g for 20 min at 10°C. 
Protein concentrations were determined using the bicinchoninic acid (BCA) assay (Pierce 
Biotechnology, Rockford, IL).  Five micrograms of protein were separated by SDS-PAGE and 
electrotransferred to polyvinylidene flouride (PVDF) membranes (Millipore, Billerica, MA) and 
probed overnight for cytochrome c oxidase IV (1:1000; Cell Signaling, Beverly, MA) and with a 
cocktail containing antibodies against the following proteins (1:1000): Complex I subunit 
NDUFB8, Complex II subunit 30kDa, Complex III subunit Core 2, Complex IV subunit II, and 
ATP synthase subunit alpha (Mitosciences, Eugene, OR).  Membranes were incubated for 1h at 
room temperature with the corresponding secondary antibody and the immunoreactive proteins 
were detected using enhanced chemiluminescence (ChemiDoc XRS+ Imaging System, BioRad 
Laboratories, Inc., Hercules, CA).  Samples were normalized to a crude muscle homogenate 
sample on each gel to normalize for blotting efficiency across gels. 
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A 10-15 mg piece of muscle was diluted 20-fold in a buffer containing 100 mM KH2PO4 
and 0.05% bovine serum albumin and homogenized at 4°C using a Bullet Blender.  
Homogenates went through four freeze-thaw cycles before experimentation.  This homogenate 
was used for determining citrate synthase (CS) and beta-hydroxyacyl coenzyme A 
dehydrogenase (HAD) activity.  Protein content was measured using the BCA assay.  Citrate 
synthase activity was assessed with reagents provided in a kit (Sigma CS0720), which used a 
colorimetric reaction to measure the reaction rate of acetyl coenzyme A and oxaloacetic acid.  
Activity of HAD was measured using methods described previously (32), and rates were 
determined by calculating the rate of disappearance of NADH after the addition of acetoacetyl 
coenzyme A. 
Statistical analyses. Repeated-measures analysis of variance was used to compare the data.  
Post-hoc analyses were performed using contrast-contrast analysis.  Statistical significance was 
set at p<0.05, and all data are expressed as mean ± SEM.  Due to limitations in tissue size, all 
measurements could not be obtained for all individuals; the n for each variable is indicated. 
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Results 
Subject characteristics. Anthropometric data are presented in Table 2.1 for the 12 lean and 10 
obese men.  Body mass, BMI, fasting insulin, and HOMA-IR were significantly higher in obese 
subjects (p<0.01).  Blood lipids, glucose, and insulin did not change as a result of the high-fat 
diet or exercise training, and all subjects remained weight-stable throughout the duration of the 
study.  The diet composition was similar between lean and obese subjects (72% fat, 15% 
carbohydrate, 13% protein), and provided a significant increase in dietary fat over their normal 
consumption recorded in a 3-day food log before commencement of the study which contained 
35% fat, 48% carbohydrate, 17% protein. 
Fatty acid oxidation in skeletal muscle. Fatty acid oxidation in response to the high-fat diet and 
exercise are presented in Fig. 2.2.  The lean subjects increased complete palmitate oxidation 
(
14
CO2 production) by 27% in response to the 3 day HFD (p=0.02) indicating metabolic 
flexibility in response to an increase in ingested lipid.  However, there was essentially no 
alteration in complete FAO in the obese group (1% increase vs. pre-diet values (Fig. 2.2), 
indicating a lack of metabolic flexibility.  Exercise training (p=0.02) and 10d exercise plus 3d 
HFD (p=0.002) increased FAO above pre-exercise levels in both groups; however, in relation to 
metabolic flexibility, there was no significant increase in FAO with the addition of the high fat 
diet after the 7 days of exercise (Fig. 2.2).  Total FAO (overall average 1450.8 nmol/mg 
protein/min) and ASM (overall average 1157.3 nmol/mg protein/min) did not change with the 
high-fat diet or exercise training, and were not different between lean and obese (data not 
shown).    
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Skeletal muscle enzyme activities/protein content. Enzyme activities for CS and HAD are 
presented in Fig. 2.3A and 2.3B, respectively.  In the sedentary state, CS activity exhibited a 
pattern similar to complete FAO (Fig 2.3A), with a tendency for the lean subjects to increase 
(12.3±7.3%, p=0.17) in response to the high fat diet and obese to have an attenuated response 
(2.3±8.9% decrease from pre-diet values).  Seven days of exercise training increased CS activity 
in both groups over the sedentary condition (p=0.02) with no further change at 10 days of 
exercise plus the 3-day high fat diet (p=0.03 compared to sedentary pre-diet).  The trends for 
HAD responses to a high-fat diet and exercise training were similar to CS, with a high-fat 
diet+exercise increase that approached statistical significance (p=0.07 compared to sedentary 
pre-diet; Fig. 2.3B).  Protein content of Complex II, III, IV, and ATP synthase subunits did not 
change with the high-fat diet or exercise training, and were not different between lean and obese 
individuals (Fig. 2.4A-D). 
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 Discussion 
The metabolic inflexibility evident with obesity was first reported by Kelley and 
colleagues, who observed an inability to increase glucose oxidation in response to 
euglycemic/hyperinsulinemic conditions in obese individuals (17).  In relation to increased lipid 
presence with a high fat diet, both whole-body fat oxidation (1) and the transcription of genes 
regulating fat oxidation in skeletal muscle (3) did not increase in obese subjects compared to 
their lean counterparts.  The ability to adjust FAO in response to lipid intake is a critical indicator 
of metabolic health, as inflexibility may lead to a positive fat balance (34) and excessive weight 
gain (26).  For example, Zurlo and colleagues found that a dampening in the capacity to utilize 
lipid, as determined by whole-body RER, was associated with future weight gain in Pima Indians 
(39).  In relation to intervention, lipid oxidation capacity in skeletal muscle can increase with 
relatively short-term (10d) endurance-oriented exercise training in both lean and obese 
individuals (2); however, it is not evident if exercise training can also rescue the metabolic 
inflexibility evident with obesity.  The main findings of the present study were that:  1) obese, 
but relatively young individuals are metabolically inflexible in terms of increasing FAO capacity 
in skeletal muscle in response to a high fat diet and 2) exercise training increases the capacity for 
FAO in skeletal muscle in both lean and obese individuals, but does not dramatically potentiate 
metabolic flexibility.   
In the current study, lean, but not obese, individuals increased skeletal muscle lipid 
oxidation capacity in response to the HFD (Fig. 2.2).  This corresponds with other studies of lean 
and obese individuals at the whole-body level (1, 34).  The handling of fuel substrates (glucose, 
fatty acids, and amino acids) in the cells and tissues of healthy, lean individuals is regulated by 
fuel sensors, which activate or inhibit metabolic pathways depending on the availability and 
 17 
 
perceived needs of the cell.  Increasing lipid availability in a lean, healthy individual, such as 
with several days of a HFD, activates pathways involved in increasing lipid oxidation to 
accommodate for this fatty acid overload and perhaps restore overall fat balance.  Obese 
individuals have a diminished ability to increase lipid oxidation genes in response to a HFD (3), 
which suggests activation of these pathways is attenuated as well, thus contributing to positive 
lipid balance in skeletal muscle and other tissues (13). 
 A novel feature of our study was the inclusion of short-term aerobic exercise training as a 
means for improving skeletal muscle lipid oxidation capacity and perhaps metabolic flexibility.  
As predicted, we observed that 7d of exercise training increased skeletal muscle FAO to the 
same extent in both the lean and obese subjects (Fig. 2.2).  Similar findings were found in lean, 
obese, and post-gastric bypass subjects (2), and in lean and obese Caucasian and African-
American women (9) after 10d of exercise, suggesting that skeletal muscle lipid oxidation 
responds rapidly regardless of body habitus.  However, no studies have looked at the effect of 
exercise training on metabolic flexibility, which would be the ability to potentiate FAO with the 
addition of a HFD.  We saw that neither lean nor obese individuals increased their ability to 
elevate FAO in response to the HFD with exercise training (Fig. 2).  However, exercise training 
increased FAO equivalent to or beyond the increment seen in response to the HFD alone (Fig. 
2.2).  These findings suggest that a high absolute capacity for FAO can render the muscle 
effective in terms of adjusting to increased dietary lipid.  
Citrate synthase and HAD enzyme activities, along with electron transport chain protein 
content, were unchanged in response to the high-fat diet (Figs. 2.3A-B; 2.4A-D).  Other studies 
have shown a HFD-induced increase in whole-body and skeletal muscle lipid oxidation in the 
absence of changes in indices of mitochondrial volume (14, 36), suggesting that different 
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mechanisms can be responsible for the high-fat diet-induced increases in lipid oxidation.  
Pyruvate dehydrogenase kinase 4 (PDK4), an enzyme that inhibits activity of the pyruvate 
dehydrogenase complex (PDH) and is crucial in the partitioning of carbohydrate and lipid 
substrates, appears to respond rapidly to increases in lipid (8).  A high-fat (70% total calories) 
diet significantly increased PDK4 protein content and overall PDK activity in lean individuals 
after only one day (23), and PDK4 mRNA was increased in lean, but not obese individuals after 
a 5-day 60% fat diet (3).  Increases in PDK4 protein are associated with reduced PDH activity 
(8) and increased lipid oxidation (6).  Although limitations in tissue size prevented us from 
investigating PDK4 content and/or activity, differences in PDK4 content between lean and obese 
in response to exercise combined with a high-fat diet may help explain lipid oxidation responses 
to the intervention. 
 The activities of CS and HAD in response to exercise training mirrored the pattern of 
FAO changes we observed, with CS activity increasing after 7d of exercise and 10d exercise 
combined with the HFD and HAD tending to increase after combined diet and exercise (Fig. 
2.3A-B).  Aerobic exercise training has been shown to be a potent mechanism for improving 
maximal activity and content of mitochondrial proteins (5, 31, 33) in as little as 7-14d of training 
in lean individuals.  Similar to our FAO data, we did not see an increase in enzyme activities 
with the addition of a HFD during exercise training, compared to exercise training alone (Fig. 
2.3A-B).  Although previous research in rats have shown an additive effect of exercise training 
and a HFD on CS and HAD activities in rodents (7, 29), these enzymes did not change with 
several weeks of a HFD in endurance-trained humans (14), even though they observed increases 
in whole-body lipid oxidation.  This suggests perhaps that increased fat consumption exerts 
different effects on the mitochondria in humans compared to rodents.  Nevertheless, as CS is 
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presumed to provide a reflection of overall mitochondrial content (37) the CS activity increases 
after training in our study may be an important factor contributing to increasing skeletal muscle 
FAO in obese individuals. 
 Protein content of electron transport chain enzymes were unchanged with a high-fat diet 
and exercise training, and were not different between lean and obese individuals (Fig. 2.4A-D).  
Exercise-induced adaptations in the mitochondria are thought to involve increases in the mRNA 
expression of transcription factors, nuclear receptors, and mitochondrial proteins 4-24h following 
a single exercise session (20, 25), although mitochondrial protein content does not change within 
this time frame (20).  It is hypothesized that changes in protein content of transcription factors, 
such as peroxisome proliferator-activated receptor γ co-activator (PGC-1α), nuclear receptors 
such as the PPARs, and mitochondrial proteins, require an accumulation of these post-exercise 
mRNA bursts (12, 24, 38).  Furthermore, the temporal pattern of expression may vary among the 
enzymes, as Perry and colleagues showed CS and HAD enzyme activities increased after 6d 
training, while COX IV protein did not show changes until 10d training (22).  Since the Perry et 
al. study showed a significant 20% increase in COX IV protein after 10d exercise training, we 
expected to see increases in the protein content of COX IV and other subunits of electron 
transport chain proteins.  However, the exercise training protocol of our study was relatively 
moderate (1h at 70% VO2peak) compared to the one employed by Perry et al, who used a 
relatively high volume of interval training (10x4 min intervals at ~90% VO2peak).  Therefore, 
the higher intensity of the former protocol may have elicited a more robust response in the 
mitochondria compared to our study. More research should investigate the temporal response of 
mitochondrial proteins to exercise, as well as the potential influence of intensity on 
mitochondrial protein increases. 
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Extensive research has supported the ability of exercise training to improve lipid 
oxidation and mitochondrial capacity in the skeletal muscle of lean sedentary individuals (30, 33, 
35).  However, the ability of obese individuals to increase skeletal muscle mitochondrial 
capacity, and thus lipid oxidation, is controversial.  One study showed that obese, insulin-
resistant individuals failed to increase mRNA expression of PGC-1α and its downstream gene 
targets to the same extent as their lean counterparts after a single bout of aerobic exercise (10).  
However this study did not directly assess skeletal muscle lipid oxidation or whether this 
attenuated response continued after several days of training.  Another study shows that a 16-
20wk aerobic exercise training program increased mtDNA content in lean, but not obese 
individuals (27).  Nevertheless, other studies support the hypothesis that obese individuals can 
increase skeletal muscle lipid oxidation in response to training: Bruce and colleagues showed a 
120% increase in skeletal muscle lipid oxidation after eight wk of aerobic exercise training in 
obese (average BMI 36 kg/m
2
) individuals (4).  Furthermore, our previous research shows that 
the increase in skeletal muscle lipid oxidation in response to 10d training is similar between lean 
and obese individuals (2).  The present findings support the concept that endurance-oriented 
exercise training can increase the capacity for FAO in the skeletal muscle of obese individuals 
and that this adaptation occurs to the same relative extent as in their lean counterparts.  
 In conclusion, 3d of a 70% eucaloric fat diet increased lipid oxidation in the skeletal 
muscle of  lean individuals but did not alter FAO in obese individuals, indicating metabolic 
inflexibility in response to an increase in ingested lipid.  Short-term aerobic exercise training 
increased lipid oxidation and CS activity similarly in both lean and obese individuals, although 
HFD-induced metabolic flexibility did not appear to improve in either group.  Together, these 
findings suggest that the increase in FAO in skeletal muscle with endurance-oriented exercise 
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training may enable obese individuals to respond similarly to their lean counterparts when 
confronted with an increase in dietary lipid load. 
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Tables and Figures 
Table 2.1. Subject characteristics. 
 Lean (n=12) Obese (n=10) 
Age (y) 21.8±1.1 22.4±0.8 
Height (cm) 178.9±2.0 179.1±2.2 
Mass (kg) 72.2±2.4 108.4±3.3* 
BMI (kg/m
2
) 22.6±0.7 33.7±0.7* 
Body Fat (%) (DEXA) 17.7±1.8 37.5±1.8* 
Fasting glucose (mmol/L) 4.7±0.1 4.7±0.1 
Fasting insulin (uU/L) 6.4±1.2 11.3±1.2* 
HOMA-IR 1.3±0.2 2.4±0.3* 
Plasma cholesterol (mg/dl) 153±9 178±12 
Plasma triglycerides (mg/dl) 86±9 113±12* 
VO2 peak (ml/kg/min) 36.7±1.2 27.2±1.2* 
VO2 peak (l/min) 2.6±0.2 2.9±0.2 
 
Results are expressed as mean±SEM 
*Significantly different (P < 0.05) from lean. 
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Figure 2.1. Study design. All subjects were screened and tested for maximal aerobic capacity 
before commencement of the study.  Within 4 weeks of screening, subjects underwent a fasting 
muscle biopsy of the vastus lateralis, consumed an isocaloric 70% high fat diet (HFD) for 3d, 
and then had another muscle biopsy the morning after the final day of the HFD.  After a 2-3 
week washout period, subjects began exercise training for 10 consecutive days, 1h/d, @ 70% 
VO2peak.  On the morning of day 8, subjects had a muscle biopsy and began consuming the 
HFD during days 8-10 of exercise training.  The day after finishing the exercise training and 
second HFD, subjects underwent their final muscle biopsy. 
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Figure 2.2.  Complete palmitate oxidation (
14
CO2 production from palmitate) in skeletal muscle 
biopsies before (pre-diet) and following a 3-day high-fat diet in the sedentary condition (3d 
HFD, sedentary) for lean (n=9) and obese (n=8) males. After a 2 to 3-week washout period 
(indicated by hashed lines), subjects performed 10 consecutive days of aerobic exercise training 
and 
14
CO2 production from palmitate was measured after 7 days of exercise and after a 3-day 
high-fat diet+ 10 days exercise.  Results are expressed as mean ± SEM.  *Significantly different 
from obese after the 3 day high fat diet (p=0.02); 
†
Significantly increased compared to the pre-
diet condition for lean (p=0.02); 
‡
Significant treatment effect for 7 days exercise compared to the 
pre-diet condition (p=0.02); 
§
Significant treatment effect for the 10 day exercise + high fat diet 
compared to the pre-diet condition (p<0.01). 
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Figure 2.3. Citrate synthase (Panel A) and HAD (Panel B) pre-diet and after 3 days of a high-fat 
diet (HFD).  After a 2 to 3-week washout period (indicated by hashed lines), subjects exercised 
for 10 consecutive days and enzyme activities were measured after 7 days exercise training and 
concurrent 10d exercise training and 3d HFD.  CS activity was determined from 12 lean and 9 
obese subjects, while HAD was determined from 10 lean and 8 obese subjects.  Results are 
expressed as mean ± SEM.  
‡
Significant treatment effect for 7 days exercise compared to the pre-
diet condition (p=0.02);
 §
Significant treatment effect for the 10 day exercise + high fat diet 
compared to the pre-diet condition (p=0.03). 
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Figure 2.4. Protein content of mitochondrial electron transport chain enzyme subunits before and 
after a 3d HFD in the sedentary condition (pre-exercise), and before and after a 3d HFD 
consumed during days 8-10 of a 10d exercise training program. Panel A: ATP synthase subunit 
alpha; Panel B: Complex III Core 2; Panel C: COX IV; Panel D: Complex II 30kDa.  Results are 
expressed as mean ± SEM.   
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CHAPTER 3: EFFECTS OF INCREASED LIPID AND CELL ENERGY EXPENDITURE ON 
MITOCHONDRIAL CONTENT IN CULTURED MYOTUBES FROM LEAN AND OBESE 
HUMANS. 
Abstract 
Human skeletal muscle cells raised in culture (HSkMC) as well as skeletal muscle in vivo from 
obese individuals are characterized by an inability to increase mitochondrial content in response 
to increased lipid.  Exercise training increases lipid oxidation in skeletal muscle which in turn 
enables lean and obese individual to respond equivalently to a high fat diet.  The purpose of the 
present study was to determine if increasing substrate turnover via pharmacological uncoupling 
could augment mitochondrial content and in turn normalize the response to lipid (metabolic 
flexibility) in obese skeletal muscle in a manner similar to exercise.  HSkMC from 10 lean (BMI 
22.1±0.8 kg/m
2
) and 10 obese (BMI 35.5±1.9 kg/m
2
) were examined under the following 
conditions: 1) Control, 2) 24h lipid incubation (FAT), 3) 72h incubation with the chemical 
uncoupler FCCP (FCCP), and 4) 48h of FCCP +24h combined FCCP and lipid (FCCP+FAT). 
Protein content of OXPHOS enzymes, citrate synthase activity, and respiration rates were 
measured.  FAT incubation increased Complex I, Complex III, and COX IV protein content in 
lean, but not obese HSkMC.  FCCP and FCCP+FAT increased Complex I irrespective of obesity 
status, while COX IV and Complex III (p=0.08) increased in only the lean subjects.  Basal and 
maximal O2 consumption increased with FCCP+FAT.  These findings indicate that the skeletal 
muscle of obese individuals exhibits a decrement in the ability to increase the expression of key 
OXPHOS proteins with lipid exposure which is not completely rescued with accelerated cell 
respiration.  Keywords: mitochondria, skeletal muscle, uncoupling, fatty acid
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Introduction 
 Obesity is increasing in its prevalence and is associated with metabolic dysfunction and 
disease (8).  An important indicator of metabolic health is metabolic flexibility, which is the 
ability to appropriately adjust substrate utilization based on availability (10).  With obesity there 
are impairments in metabolic flexibility in response to increased lipid presence, as indicated by a 
dampened ability to increase whole-body lipid oxidation (1) as well as the transcription of genes 
involved in lipid metabolism in skeletal muscle (5) with the imposition of a high-fat diet.  
Human skeletal muscle cells raised in culture (HSkMC) from obese donors also display an 
inability to increase lipid-fueled cell respiration and the expression of proteins linked with fatty 
acid oxidation in response to prolonged (24h) lipid incubation (6) indicating that this impairment 
in metabolic flexibility is a resilient and persistent trait.  
In terms of intervention, endurance-oriented exercise training increases lipid oxidation in 
skeletal muscle (2) which permits obese individuals to respond similarly to a high fat diet as lean 
subjects (Battaglia et al, in review).  In muscle, exercise induces multiple acute alterations that 
promote mitochondrial biogenesis, including increased AMP:ATP ratio, oscillations in 
intracellular Ca
2+
, increases in reactive oxygen and nitrogen species, and mechanical stress (12, 
17).  The increase in mitochondrial content with exercise results in a more oxidative phenotype, 
which may enhance the ability to appropriately regulate lipid oxidation when exposed to excess 
lipid substrate (12).  In respect to discerning cellular mechanisms by which exercise rescues 
metabolic flexibility, uncoupling of the proton gradient into the mitochondrial matrix may 
accelerate substrate use and cell respiration in a manner that may be similar to aerobic exercise.  
In 10T ½ fibroblasts 72h incubation with the chemical uncoupler carbonyl cyanide p-
(triflurometoxy) phenyl hydrazone (FCCP) increased the expression of genes involved in 
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peroxisome proliferator-activated receptor-coactivator-1α (PGC-1α) mediated mitochondrial 
biogenesis (18).  However, FCCP has a narrow functional range outside of which leads to cell 
death (13), and the dose of FCCP used in this study was 25 to 50-fold higher than the dose used 
to elicit maximal cell respiration in human myotubes.  Furthermore, since the study measured 
transcription of genes involved in mitochondrial biogenesis, it is unknown if FCCP treatment 
results in functional increases in mitochondrial protein content and cell respiration capacity, thus 
enabling the cell to respond to high lipid presence.  The intent of the present study was to 
determine if accelerating mitochondrial respiration rate via pharmacological uncoupling is one of 
the critical factors that increases mitochondrial content and restores metabolic flexibility in the 
skeletal muscle of obese individuals with lipid overload, i.e. in a manner akin to endurance-
oriented exercise.  This was accomplished by 1) determining if HSkMC from obese donors 
exhibit an impaired response to lipid incubation in terms of increasing mitochondrial content and 
cell respiration, and 2) whether increasing substrate turnover within the cell could rescue any 
observed impairments in metabolic flexibility with obesity. 
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Methods 
Study design. The intent of this study was to determine if pre-treatment with a chemical 
uncoupler (FCCP) improved metabolic flexibility to lipid overload in HSkMC from lean and 
obese donors.  Satellite cells were derived from muscle biopsies and were subsequently 
differentiated into myotubes as described previously (3).  Cells from each subject were divided 
into multiple wells, which were subdivided into the following four conditions (Fig. 3.1): Control, 
1:1 100 µM oleate:palmitate incubation over the final 24h of differentiation (FAT), 400 nM 
FCCP (FCCP) over the final 72h of differentiation, and 48h of FCCP incubation+24h combined 
FCCP and lipid (FCCP+FAT).  After the treatments, western blots of OXPHOS enzymes 
(Complex I subunit NDUFB8, Complex II subunit 30kDa, Complex III subunit Core 2, 
cytochrome c oxidase subunit IV, and ATP synthase subunit alpha) and citrate synthase enzyme 
activity were used as indices of mitochondrial content.  Cell respiration was determined using a 
Seahorse Bioscience XF24 Extracellular Flux Analyzer.   
Subjects. Skeletal muscle was obtained from the vastus lateralis in 10 lean (BMI 22.1 ± 0.8 
kg/m
2
) and 10 obese (BMI 35.5 ± 1.9 kg/m
2
) males age 18 - 26y.  Participants filled out a 
medical history questionnaire to confirm they were free from disease, did not smoke, and were 
not taking any medications known to influence carbohydrate or lipid metabolism.  Subjects were 
weight-stable (± 2 kg over the past 3 months) and nonsmokers.  The experimental procedure and 
associated risks were explained in detail in written and oral format and informed consent 
obtained. The study was approved by the East Carolina Policy and Review Committee on 
Human Research and was in accordance with the Declaration of Helsinki. 
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Cell Culture. Satellite cells were isolated from 50-100 mg of muscle tissue as previously 
described (3).  Cells were thawed and sub-cultured in T-75 flasks and at 80-90% confluence, 
were lifted with 0.05% trypsin EDTA, and centrifuged for 10 min.  The resuspended pellet was 
plated onto 6-well type I collagen-coated plates and 24-well Seahorse XF plates (Seahorse 
Bioscience, North Billerica, MA) at a density of 8x10
5  
and
 
1x10
5
 cells per well, respectively. At 
70-80% confluence, differentiation was initiated by replacing growth media with differentiation 
media, which consisted of Dulbecco Modified Eagle’s Medium (DMEM) supplemented with 2% 
horse serum, 0.5 mg/ml fatty acid-free bovine serum albumin (BSA), 0.5 mg/ml fetuin, and 50 
ug/ml gentamycin/amphotericin B.  Differentiation media was changed every 48h.  On day 4, 
fresh differentiation media containing 0.04% molecular-grade ethanol was added to the control 
and FAT wells, and media containing 400nM FCCP dissolved in ethanol was added to the FCCP 
and FCCP+FAT wells.  On day 6, fresh differentiation media containing 0.04% ethanol and 
0.5% BSA (control), 0.04% ethanol and 100 µM 1:1 oleate:palmitate treatment (FAT), 400 nM 
FCCP and 0.5% BSA (FCCP), and 400 nM FCCP and 100µM oleate:palmitate (FCCP+FAT) 
was added to the respective wells.  Cells were harvested on day 7 for experiments.   
Dose response. High doses of FCCP can result in impaired ATP production and cell death (13).  
Furthermore, while 72h incubation with 25 µM FCCP in 10T ½ fibroblasts increased mRNA 
transcripts of genes involved in mitochondrial biogenesis (18), we found reduced whole-cell 
respiration rates in response to an acute injection of 2-4 µM FCCP in HSkMC (data not shown).  
Therefore, we measured lipid oxidation and mitochondrial protein content in response to 72h 
FCCP incubations with a variety of concentrations lower than 1 µM, with the intent of finding 
the optimal concentration for eliciting maximal increases in lipid oxidation and mitochondrial 
content.  Lipid oxidation increased significantly with 200 nM (p=0.003, 1.7-fold increase over 
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basal) and 400 nM FCCP (p=0.03, 1.7-fold increase over basal) incubations compared to control 
cells, with no increase in lipid oxidation at a concentration of 600 nM FCCP (Fig. 3.3).  Protein 
content for the majority of mitochondrial enzymes (Complex I subunit NDUFB8, Complex II 
subunit 30kDa, Complex III subunit Core 2, cytochrome c oxidase subunit IV, and ATP synthase 
subunit alpha) and citrate synthase activity increased optimally at the 400 nM concentration (Fig. 
3.4A-F).  Based on this information, 400 nM FCCP was used as the concentration for all 
subsequent studies. 
 Lipid oxidation. On day 7 of differentiation, myotubes were incubated for 3h at 37⁰C in sealed 
24-well plates containing differentiation media, 12.5 mmol/l HEPES, 0.5% BSA, 1 mmol/l L-
carnitine, 100 µmol/l sodium oleate (Sigma-Aldrich, St Louis, MO), and 1 µCi/ml [
14
C] oleate 
(PerkinElmer, MA).  Following incubation, the medium was assayed for 
14
CO2 to measure 
complete fatty acid oxidation as previously described (14).  Cells were washed twice with PBS, 
harvested in 200µl of 0.05% SDS lysis buffer, and stored at -80⁰C for determination of protein 
concentration. 
Protein content. Cells were harvested in 100 µl ice-cold lysis buffer (50 mM HEPES [pH 7.4], 
10  mM EDTA, 100 mM NaF, 12 mM Na pyrophosphate, 1% Triton X-100) supplemented with 
protease and phosphatase inhibitors (Sigma-Aldrich).  Samples were sonicated, rotated end-over-
end at 4⁰C for 1h, and centrifuged at 20,000g for 20 min at 4⁰C.  Protein concentrations were 
determined using the bicinchoninic acid (BCA) assay (Pierce Biotechnology, Rockford, IL). 
Twenty micrograms of protein were separated by SDS-PAGE and electrotransferred to 
polyvinylidene flouride (PVDF) membranes (Millipore, Billerica, MA) and probed overnight for 
cytochrome c oxidase (COX) IV (1:1000; Cell Signaling, Beverly, MA) and with a cocktail 
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containing antibodies against the following proteins (1:1000): Complex I subunit NDUFB8, 
Complex II subunit 30kDa, Complex III subunit Core 2, Complex IV subunit II, and ATP 
synthase subunit alpha (Mitosciences, Eugene, OR; Fig. 3.2).  Membranes were incubated for 1h 
at room temperature with the corresponding secondary antibody and the immunoreactive 
proteins were detected using enhanced chemiluminescence (ChemiDoc XRS+ Imaging System, 
BioRad Laboratories, Inc., Hercules, CA).  Samples were normalized to a crude cell sample on 
each gel to normalize for blotting efficiency across gels.   
Citrate synthase activity. Cells were harvested in 100 µl of a buffer containing 100 mM 
KH2PO4, 0.05% bovine serum albumin, and 0.08% Triton X-100.  Samples were centrifuged at 
20,000g for 20 min at 4⁰C.  Protein concentrations were determined using a BCA assay kit, and 
all samples were diluted to 1.0 ug/ul using potassium phosphate buffer.  Citrate synthase activity 
was determined using reagents provided in a kit (Sigma CS0720, St. Louis, MO), which used a 
colorimetric reaction to measure the reaction rate between acetyl coenzyme A and oxaloacetic 
acid. 
Cellular respiration. On day 7 of differentiation, cell oxygen uptake rates (OCR) and 
extracellular acidification rates (ECAR) were measured in real-time using a Seahorse Bioscience 
XF24 Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA).  Cells were 
washed with unbuffered DMEM, and preincubated for 1h at 37°C without CO2 in 600 µL of 
unbuffered DMEM assay media (pH 7.4) supplemented with 1 mM sodium pyruvate and 200 
µM 1:1 oleate:palmitate prior to the measurements.  Following basal rates (OCR and ECAR in 
response to presence of substrate only), 2,4 dinitrophenol (DNP) (Sigma-Aldrich, St. Louis, MO) 
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was injected to a final concentration of 1 µM to measure maximal OCR rate under uncoupled 
conditions as an index of possible changes in total mitochondrial content.   
Statistical analyses. Statistical analyses were performed using IBM SPSS Statistics 19 software 
(IBM Headquarters, Armonk, NY).  Repeated-measures analysis of variance was used to 
compare the data.  Post-hoc analyses were performed using contrast-contrast analysis.  Statistical 
significance was set at p < 0.05, and all data are expressed as mean ± SEM. 
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Results 
Subject characteristics. Subject characteristics are presented in Table 3.1.  By design, obese 
individuals were heavier and had a significantly higher body mass index (BMI) than lean 
subjects (p<0.001).  The obese group were also insulin-resistant compared to their lean 
counterparts, as indicated by HOMA-IR (p=0.01), and had significantly higher fasting insulin 
and total cholesterol levels (p=0.01 and 0.03, respectively).  The obese group was also slightly 
older (22.4±0.8y) than the lean group (19.9±0.7y; p=0.02). 
Mitochondrial Content 
Lipid Treatment. Indices of mitochondrial content in response to 24h incubation with 100 µM 
1:1 oleate:palmitate are presented in Fig. 3.5A.  Indicative of metabolic flexibility, myotubes 
from lean individuals significantly increased the content of Complex I (p=0.05), Complex III 
(p=0.01), and COXIV subunits (p=0.04) in response to lipid incubation.  In contrast, there were 
no changes in protein content in the obese individuals.  Protein content of Complex II, Complex 
V, and citrate synthase activity did not change with lipid incubation in either of the subject 
groups.   
FCCP Treatment. The 72h FCCP incubation significantly increased Complex I protein content 
(p=0.03) and Complex III protein content (p=0.005) (Fig. 3.5B) regardless of subject group 
(treatment effect).  For Complex III, the increase in protein content tended to be greater (p=0.08) 
in cells from lean subjects (22% increase from control) than obese cells (6% increase from 
control).  COXIV protein increased in the cells from lean (p=0.02) but not obese donors with 
FCCP treatment.  Similar to the lipid incubation condition, there were no significant increases in 
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citrate synthase activity or protein content of the Complex II and Complex V enzyme subunits 
after the 72h FCCP incubation. 
FCCP +Lipid Treatment. Similar to the FCCP only condition, the combined FCCP and lipid 
treatment significantly increased protein content of the Complex I (p=0.02) and Complex III 
subunits (p=0.04) (Fig. 3.5C).  As with the FCCP treatment alone, the increase in Complex III 
was primarily driven by the lean subjects as the difference between the lean and obese subjects 
approached significance (p=0.08).  Similar to the FCCP alone treatment, there was a differential 
response of COXIV with the lean subjects increasing and no change in the obese (p=0.04).  
Citrate synthase activity and the protein content from Complex II and V enzymes did not change 
with combined FCCP and lipid treatment. 
Oxygen Consumption . Substrate-only and DNP-stimulated oxygen consumption rates are 
presented in Fig. 3.6A-B.  Oxygen consumption rates with the substrate only were higher after 
the 72 hr combined FCCP and lipid incubation compared to all other conditions (p<0.05).  With 
DNP-stimulation, lipid-treated cells had higher oxygen consumption rates than control cells 
(p=0.01).  Combined lipid and FCCP treatment increased DNP-stimulated oxygen consumption 
over Control (p=0.03), lipid-only (p=0.03), and FCCP-only (p<0.001) conditions.  Oxygen 
consumption responses did not differ between lean and obese for any of the conditions.  
Extracellular acidification rates did not change in response to any of the conditions and were not 
different between lean or obese (data not shown). 
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Discussion 
 The skeletal muscle of obese individuals does not appear to respond appropriately to an 
increase in lipid availability.  For example, HSkMC from obese individuals do not alter lipid-
fueled cell respiration following a 24h lipid incubation in contrast to the increase seen in cells 
from their lean counterparts (6).  Similarly, exposure to a high-fat diet increased lipid oxidation 
and the expression of genes linked with mitochondrial biogenesis in the skeletal muscle of lean, 
but not obese subjects (5).  In terms of intervention, both lean and obese individuals responded 
similarly to a high fat diet in terms of fatty acid oxidation in skeletal muscle after 10 consecutive 
days of endurance training (Battaglia et al, in review), and exercise training increased fatty acid 
oxidation and the mRNA content of genes linked with mitochondrial biogenesis regardless of 
obesity status (2).  The intent of the present study was to determine whether accelerating 
mitochondrial respiration via chemical uncoupling in HSkMC could increase mitochondrial 
content and rescue the impaired ability to respond to lipid exposure in obese individuals in a 
manner resembling exercise training.  The primary findings were that 1) lean, but not obese, 
individuals increased the content of proteins involved in oxidative phosphorylation (Complex I, 
Complex III, COXIV) in response to lipid incubation (FAT condition), consistent with 
impairments in metabolic flexibility with obesity and 2) chemical uncoupling (FCCP treatment) 
and chemical uncoupling + lipid incubation (FCCP + FAT) increased Complex I and Complex 
III content irrespective of body habitus, while COXIV only increased in myotubes from lean 
individuals.  Therefore, under the experimental conditions utilized, elevating mitochondrial 
respiration via pharmacological uncoupling appears to rescue some, but not all aspects of the 
impairments in metabolic flexibility in skeletal muscle evident with obesity. 
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The activities of Complexes I and III have been shown to be rate-limiting in the oxidation 
of NADH (4) and Complex I, III, and COX enzymes may be associated in a “supramolecular 
assembly,” whereas other enzymes are organized more randomly (reviewed in (11)).  Thus, the 
selective increases in Complex I, III, and COXIV content after lipid incubation (FAT) in the lean 
subjects may allow for more efficient electron transfer throughout the mitochondrial respiratory 
chain, enabling the cell to adapt to increased lipid and ensuring metabolic flexibility (Fig. 3.5A).  
Furthermore, COXIV, a nuclear-encoded subunit of cytochrome c oxidase, is a frequently used 
index of mitochondrial content because of its role in regulating rates of respiration and ATP 
synthesis (9).  However, while Complexes I, III, and COXIV content increased in response to 
increased lipid presence in myotubes from lean donors, none of these proteins increased in the 
obese individuals (Fig. 3.5A), which is supportive of our previous observations (6) indicating an 
impairment in the regulation of genes involved in oxidative metabolism in the skeletal muscle of 
obese individuals in response to lipid.   
 A novel component of the present study involved incubating myotubes with the chemical 
uncoupler FCCP in an attempt to mimic the increased substrate turnover of in vivo exercise and 
possibly rescue metabolic flexibility in obese tissue.  An FCCP treatment effect was observed for 
Complexes I and III in HSkMC from both lean and obese donors, although the increase in 
Complex III was driven primarily by the lean subjects (Fig. 3.5B).  Furthermore, only the lean 
individuals increased COXIV protein in response to FCCP incubation (Fig. 3.5B).  These data 
are supportive of other findings indicating that the skeletal muscle of the obese can exhibit a 
dampened response to aerobic exercise in terms of triggering signals for mitochondrial 
biogenesis (7).  However, exercise training can increase lipid oxidation (2) and mitochondrial 
density (21), indicating that the skeletal muscle of the obese are also fully capable of responding 
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to the intervention.  Chemical uncoupling can activate AMPK and increase intracellular Ca
2+
 
levels in fibroblasts (18) but cannot fully mimic all aspects of exercise, such as mechanical 
contraction and oscillations in intracellular Ca
2+
 flux.  Under the experimental conditions 
utilized, the current findings suggest that convergence of these multiple factors, which occurs 
during muscle contraction, may be needed to elicit equivalent adaptive responses in the skeletal 
muscle of both lean and obese individuals. 
 Although previous research showed that incubation with 25 µM FCCP for 72h increased 
mRNA transcripts of PGC-1α, NRF-1, and OXPHOS proteins in 10T ½ fibroblasts (18), we 
observed that 400 nM FCCP for 72h was the optimal concentration for increasing lipid oxidation 
(Fig. 3.3) and mitochondrial proteins (Fig. 3.4A-F) in HSkMC.  FCCP disrupts the proton motive 
force that drives ATP synthesis and while the cell is able to increase cell respiration in response 
to a low dose, too high a concentration will ultimately lead to cell death (13).  The present study 
showed trends for lipid oxidation (Fig. 3.3) and mitochondrial protein (Fig. 3.4A-F) to decrease 
with incubation with 600nM FCCP for 72h.  This suggests that the optimal physiological 
concentration of FCCP that depolarizes the mitochondrial membrane to trigger an increase in 
substrate utilization, while keeping the majority of cells viable, at least in primary human skeletal 
muscle cells is much lower than 25 µM.   
 Differential responses of certain electron transport chain proteins to lipid exposure 
remained evident with the combined FCCP+FAT treatment (Fig. 3.5C), indicating that 
uncoupling did not fully restore this aspect of metabolic flexibility in the muscle of obese 
individuals.  However, combined FCCP+FAT incubation led to a significant increase in 
maximally stimulated respiration rate in intact myotubes from both lean and obese individuals 
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(Fig. 3.6B).  Thus, maximal cellular respiration in the intact cell did not mirror the results evident 
in respiratory chain protein content, suggesting that other mechanisms, such as an improvement 
in mitochondrial function, are involved in controlling respiration rate.     
Unlike the components of the respiratory system that were altered with lipid and/or 
chemical uncoupling in the lean subjects (Complex I, III, and IV) (Fig. 3.5A-C), Complex II, 
which accepts electrons via FADH2, does not create a proton gradient as it transfers electrons 
through the electron transport chain (11).  Pharmacological uncoupling dissipates the proton 
gradient, which may induce adaptations in proteins linked with this process rather than Complex 
II (Fig. 3.5B-C).  Unlike Complex I, III, IV, and ATP synthase, which require coordination of 
nuclear and mitochondrial genomes and are regulated by multiple assembly factors, the four 
subunits of Complex II are only encoded by nuclear genes, and the roles for Complex II 
assembly factors are not clear.  It is postulated that perhaps the cell preferentially dedicates 
proteins for synthesis of the other complexes rather than Complex II (19), and thus may explain 
the lack of Complex II response to FCCP and/or FAT that we observed (Fig. 3.5A-C).  
Furthermore, citrate synthase (CS) activity, which has been shown to respond to as little as 6-10 
d of endurance-oriented exercise training in human skeletal muscle (16, 20), did not change with 
FAT and/or FCCP incubation (Fig. 3.5A-C).  The lack of CS activity response to FAT incubation 
agrees with previous findings on CS activity in response to lipid incubation in human myotubes 
(6, 15), suggesting that high lipid load does not trigger an increase in CS activity in vitro. As 
FCCP targets the electron transport chain, it may specifically induce changes in the content 
and/or activity of enzymes involved as opposed to other energy producing pathways such as the 
TCA cycle. 
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 In conclusion, the present findings indicate that the skeletal muscle of obese individuals 
exhibits a blunted response to lipid in terms of increasing components of the respiratory chain 
(Complex I & III and COXIV).  These data support our previous findings (5, 6) of metabolic 
inflexibility in human skeletal muscle with obesity.  Accelerating mitochondrial respiration via 
incubation with a chemical uncoupling agent (FCCP) did not fully restore the ability to increase 
the expression of the respiratory proteins in response to lipid incubation in obese individuals, 
indicating that other in vitro intervention strategies are likely needed to mimic the positive 
benefits of in vivo exercise training in obese individuals.     
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Tables and Figures 
Table 3.1 Subject Characteristics 
 Lean (n=10) Obese (n=10) 
Age (y) 19.9±0.7 22.4±0.8* 
Height (cm) 177.2±1.7 179.5±2.1 
Mass (kg) 69.3±2.4 114.9±6.8* 
BMI (kg/m
2
) 22.1±0.8 35.5±1.9* 
Fasting glucose (mmol/L) 4.6±0.1 4.8±0.1 
Fasting insulin (uU/L) 6.8±1.0 12.6±1.9* 
HOMA-IR 1.4±0.2 2.7±0.4* 
Plasma cholesterol (mg/dl) 136±7 164±10* 
Plasma triglycerides (mg/dl) 75±9 118±21 
   
 
Values are expressed as mean ± SEM. 
*Significantly different from lean (p<0.05). 
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Fig. 3.1 Study Design.  Myotubes cultured from lean and obese donors were differentiated at 70-
80% confluence and incubated under the following conditions: Differentiation media 
supplemented with 2% horse serum (Control); 24h 100 µM 1:1 oleate:palmitate (FAT); 72h 400 
nM FCCP (FCCP); 48h FCCP followed by 24h FCCP and FAT (FCCP+FAT).  Cells were 
harvested for experiments on day 7. 
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Fig. 3.2 Representative Western blot of OXPHOS protein content in response to differentiation 
media supplemented with 2% horse serum (Control), 100 µM of 1:1 oleate:palmitate (FAT), 72h 
400 nM FCCP, or 48h FCCP + 24h combined FCCP and 1:1 oleate:palmitate.  The OXPHOS 
antibody cocktail contained antibodies against the following subunits: Complex I subunit 
NDUFB8 (I), Complex II subunit 30kDa (II), Complex III subunit Core 2 (III), Complex IV 
subunit II, and ATP synthase subunit alpha (V).  Complex IV subunit II could not be detected 
consistently in all of the samples; therefore, data for this protein was not analyzed. 
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Fig. 3.3 Complete oleate oxidation (
14
CO2 production from oleate) in myotubes in response to 
72h FCCP incubation. 
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Fig. 3.4 Protein content of Complex I subunit NDUFB8 (A), Complex II subunit 30kDa (B), 
Complex III subunit Core 2 (C), and ATP synthase subunit alpha (D) was measured in response 
to 72h FCCP (n=2), and COXIV protein content (E) and citrate synthase enzyme activity (F) 
were measured in 1 lean individual.  Protein content was expressed as fold-change in reference to 
the protein content of the respective control condition (control was set at 1 arbitrary unit), and 
citrate synthase activity was measured in umol/mg protein/min.  
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Fig. 3.5 Relative changes (post-treatment divided by pre-treatment) in content of Complex I 
subunit NDUFB8 (I), Complex II subunit 30kDa (II), Complex III subunit Core 2 (III), 
cytochrome c oxidase subunit IV (COX IV), ATP synthase subunit alpha (V), and citrate 
synthase (CS) activity in response to 24h incubation with 100 µM of 1:1 oleate:palmitate (FAT) 
(A), 72h 400 nM FCCP (B), or 48h FCCP + 24h combined FCCP and 1:1 oleate:palmitate (C).  
*Treatment effect for lean only; 
Ɨ
Treatment effect for both lean and obese. 
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Fig. 3.6 Substrate-only (A) and 100 µM DNP-stimulated (B) oxygen consumption in the 
presence of 1 mM pyruvate and 200 µM 1:1 oleate:palmitate in myotubes from lean and obese 
donors incubated with control media (Control), 24h 100 µM 1:1 oleate:palmitate (FAT), 72h 400 
nM FCCP (FCCP), or 48h FCCP + 24h combined FCCP and FAT (FCCP+FAT).  *Significantly 
different from control; 
Ɨ
Significantly different from FAT only; 
ǂ
Significantly different from 
FCCP only. 
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CHAPTER 4: SUMMARY OF FINDINGS 
 This dissertation examined the effects of increased lipid load and aerobic exercise 
training on skeletal muscle metabolic flexibility in lean and obese individuals using in vivo 
(study 1) and cell culture (study 2) models.  Our primary findings were 1) obese individuals have 
a blunted response to a 3-day 70% fat diet in terms of increasing skeletal muscle lipid oxidation, 
which was rescued by 10 days of aerobic exercise training and 2) similar to the in vivo high-fat 
diet (HFD), myotubes cultured from obese individuals displayed a similar inability to respond to 
increased lipid presence (24h lipid incubation) in terms of increasing mitochondrial protein 
content, which was not fully ameliorated by accelerating substrate utilization via mitochondrial 
uncoupling.  Together, this suggests that the metabolic inflexibility to high lipid loads in obese 
individuals is persistent, and while in vivo exercise training is effective for rescuing this 
inflexibility to lipid, the mechanism for this response is complex and likely involves other factors 
besides increasing mitochondrial respiration. 
 As hypothesized in study 1, 3d of an isocaloric 70% fat diet increased skeletal muscle 
fatty acid oxidation (FAO) in lean, but not obese individuals (Fig. 2.2).  This occurred in the 
absence of increases in electron transport chain protein content and activities of CS and HAD 
(Fig. 2.3A-B), indicating that perhaps improvements in substrate switching and/or mitochondrial 
function are responsible for the increased lipid oxidation.  In particular, inactivation of the 
pyruvate dehydrogenase complex (PDC) via increased pyruvate dehydrogenase kinase 4 (PDK4) 
content and/or activity could be a possible mechanism for high-fat diet-induced increases in lipid 
oxidation, as both content and activity increase after 1d of a high-fat diet in lean individuals (9), 
and lean, but not obese individuals increase PDK4 mRNA content in response to a 5-day high-fat 
diet (3).  Although we did not have sufficient tissue to measure PDK4 content and/or activity, 
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future research on metabolic flexibility in response to lipid should investigate this mechanism, as 
regulation of PDC could be instrumental in the adaptation to high-fat and/or high-carbohydrate 
diets in lean healthy individuals.  
In study 2, short-term (24h) lipid incubation in cell culture showed a similar impairment 
in metabolic flexibility in myotubes from obese donors, as lean but not obese individuals 
increased protein content of Complex I, Complex III, and COX IV from the electron transport 
chain (Fig. 3.5A).  Greater lipid presence in skeletal muscle activates the transcription of genes 
to increase oxidative capacity and enhance electron transfer efficiency in the mitochondria.  
Complex I, IIl, and COX IV may be particularly important for forming a “supramolecular 
assembly” that increases electron transfer efficiency in the mitochondria.  Therefore, the cultured 
myotubes from the lean may increase protein content of these enzymes, and perhaps oxidative 
phosphorylation capacity in response to high lipid availability.  However, the myotubes from 
obese individuals do not increase OXPHOS protein content in response to lipid incubation, 
mirroring the metabolic inflexibility we observed with our in vivo HFD in study 1.  Much like 
our previous research in cultured myotubes investigating mitochondrial DNA content (4) and 
CD36 content (1), the current findings further indicate that obese individuals have a persistent 
impairment in response to lipid incubation in cell culture, suggesting dysregulation of many 
aspects of mitochondrial content and function with obesity. 
In study 1, we investigated whether 10 days of aerobic exercise training could restore 
metabolic flexibility in response to a high-fat diet (HFD) in obese individuals. Obese subjects 
increased skeletal muscle FAO to the same extent as their lean counterparts in response to the 
high-fat diet while exercise training (Fig. 2.2), indicating that obese skeletal muscle has the 
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ability to increase FAO in response to aerobic training as we have previously indicated (2, 6).  
Neither group significantly increased FAO in response to the HFD while exercise training, 
indicating that metabolic flexibility per se, or the ability to increase skeletal muscle FAO after 
consuming a HFD, was not improved with exercise training.  However, exercise training 
increased FAO equivalent to or beyond the level seen in response to the HFD alone, suggesting 
that a high absolute capacity for FAO can help obese skeletal muscle adjust to increased dietary 
lipid and minimize positive lipid balance.  
We also observed increased citrate synthase (CS) activity with exercise training (Fig. 
2.3A), similar to previous short-term exercise training studies (8, 12), and a tendency for beta-
hydroxyacyl CoA dehydrogenase (HAD) activity to increase with exercise (Fig. 2.3B).  
However, the relatively modest increase in enzyme activity with exercise (19% increase in CS 
activity in the lean individuals) likely does not fully explain the more robust increase in overall 
FAO we observed in response to the combined diet and exercise intervention (55% increase in 
lean individuals).  Therefore, it is likely that mitochondrial function also improved with exercise 
training.  Other studies have suggested that the mitochondria of obese skeletal muscle has a 
deficit in NADH oxidase activity in the electron transport chain, perhaps promoting the 
accumulation of NADH (10), and does not increase mitochondrial DNA content to the same 
extent as lean individuals in response to 4 mo of exercise training (7).  However, our findings do 
not suggest a lean vs. obese difference in terms of the ability to increase skeletal muscle FAO in 
response to short-term exercise training combined with a HFD, further supporting our hypothesis 
that obese skeletal muscle can respond to aerobic exercise training and improve oxidative 
capacity.   
 69 
 
 To determine whether speeding up mitochondrial respiration rate in cell culture could 
mimic in vivo exercise training and increase mitochondrial content, we incubated myotubes from 
lean and obese donors with the chemical uncoupler FCCP for 72h in study 2.  However, obese 
did not appear to respond to FCCP incubation as robustly as the lean did, as the obese increased 
some, but not all, of the mitochondrial enzyme proteins we measured (Fig. 3.5B).  We based our 
FCCP incubation methods on the findings from Rohas and colleagues, who incubated 10T ½ 
fibroblasts with FCCP for 72h and observed increased transcription of PGC-1 and downstream 
mitochondrial genes, concomitant with increased AMPK activation and intracellular Ca
2+
 levels 
(11).  We did not measure AMPK activity, AMP:ATP ratios, or intracellular Ca
2+
 levels in the 
myotubes to assess the degree to which we were activating these pathways.  Therefore, while 
increasing substrate utilization via FCCP incubation did not fully mimic in vivo exercise training, 
it did lead to increases in some mitochondrial proteins in obese individuals.  Further research of 
the multiple pathways involved in exercise-induced increases in mitochondrial content will help 
clarify the mechanisms by which the obese increase skeletal muscle FAO in response to exercise 
in vivo.   
Although 72h FCCP incubation increased protein content of Complex I, Complex III, and 
COX IV enzymes in lean HSkMC (Fig. 3.5B-C), 10d aerobic exercise training in vivo did not 
increase protein content of these enzymes (Fig. 2.4A-D).  Furthermore, citrate synthase activity 
increased with 7d exercise, and 10d exercise combined with 3d high-fat diet in study 1 (Fig. 
2.3A), but did not change with in vitro FCCP or FCCP+FAT incubation in study 2 (Fig. 3.5 B-
C).  Although both interventions increase cell respiration, incubation with FCCP in vitro may 
involve a chronic depolarization of the mitochondrial membrane for the 72h period.  This may 
provide a greater stimulus to the electron transport chain enzymes that generate the proton 
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gradient across the mitochondrial membrane than the exercise training protocol employed in 
study 1, which involved 10 1h sessions of exercise interspersed by rest periods.  While FCCP 
accelerates cell respiration within the mitochondria, the effects of exercise training on skeletal 
muscle are multifaceted, and increasing mitochondrial respiration is only one part of the overall 
effect.  Muscle contraction-induced signaling, increases in skeletal muscle blood flow, and 
changes in the muscle’s hormonal environment can all contribute to the increased skeletal 
muscle FAO capacity we found in study 1.  Even at the molecular level, skeletal muscle can 
increase skeletal muscle FAO capacity via a variety of mechanisms besides increasing 
mitochondrial content, such as allowing greater transport of fatty acids into the mitochondria by 
increasing the lipid transport capacity of carnitine palmitoyltransferase-1 (CPT-1) (5).  
Therefore, accelerating substrate turnover in the electron transport chain in HSkMC in vitro had 
different effects than in vivo exercise training did on whole skeletal muscle.  
In study 2, we assessed whether combined lipid and FCCP incubation could rescue the 
lipid-induced metabolic inflexibility we observe in cultured myotubes from obese individuals, 
similar to the in vivo exercise training and HFD in study 1.  Although obese cells did not increase 
all of the mitochondrial proteins to the extent of the lean subjects (Fig. 3.5C), the combined 
FCCP+FAT incubation did increase maximally stimulated respiration rate in intact myotubes 
over control, FAT, and FCCP conditions for both lean and obese individuals (Fig. 3.6B), which 
was not in accordance with the mitochondrial content responses we observed.  Since we 
measured respiration rate in intact cells, changes could be influenced by factors such as transport 
into the cell and/or mitochondria, shifts in relative substrate utilization, substrate flux through the 
electron transport chain, or oxidation of endogenous substrates.  Respiration experiments in 
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which we isolate the mitochondria, or use inhibitors for ETC enzymes or substrates, could help 
elucidate potential mechanisms. 
 In conclusion, the findings indicate that in vivo the skeletal muscle of obese individuals 
does not adjust to increased lipid loads in terms of increasing lipid oxidation.  In cell culture, 
myotubes from obese individuals do not increase mitochondrial protein in response to lipid 
incubation to the same extent as their lean counterparts, indicating a persistent impairment with 
obesity.  Short-term exercise training rescues the response to a HFD in obese individuals; 
however, increasing substrate turnover in an in vitro cell culture model does not completely 
restore lipid-induced metabolic flexibility, suggesting that other factors contribute to the effects 
of exercise training on the response to increased lipid loads in vivo and should be further 
examined.  
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